SENORES.NS
SENORES · Corporate filings
NSE
Financial Charts & Report quarterly revenue, profit, margins, growth, and price overlay
Stock market charts for SENORES.NS quarterly results: revenue, profit, margins, growth, and filing-derived operating metrics.
Loading financial charts...
Results Change Summary quarter-on-quarter and year-on-year filing evidence
Generate an evidence-linked summary of revenue, margin, profit, debt, cash and operating cash flow changes.
Financial Results figures in ₹ crore, except EPS/%
Loading…
Relative Returns vs Sector, Nifty 50, Sensex, Nifty 500
Loading…
CAN SLIM William O'Neil's growth-stock criteria
Loading…
Latest Shareholding Pattern promoter, FII, DII, public and institution trend
NSE synced data
Corporate Governance SEBI integrated governance filing
NSE synced data
Loading governance disclosure...
Announcements
Analysts/Institutional Investor Meet/Con. Call Updates
21 Jul 2026
Certificate under SEBI (Depositories and Participants) Regulations, 2018
08 Jul 2026
Certificate under SEBI (Depositories and Participants) Regulations, 2018
07 Jul 2026
Copy of Newspaper Publication
03 Jul 2026
Shareholders meeting
02 Jul 2026
Analysts/Institutional Investor Meet/Con. Call Updates
01 Jul 2026
Outcome of Board Meeting
30 Jun 2026
Trading Window
26 Jun 2026
General Updates
11 Jun 2026
Cessation
11 Jun 2026
Analysts/Institutional Investor Meet/Con. Call Updates
09 Jun 2026
Analysts/Institutional Investor Meet/Con. Call Updates
04 Jun 2026
Analysts/Institutional Investor Meet/Con. Call Updates
22 May 2026
Analysts/Institutional Investor Meet/Con. Call Updates
20 May 2026
Analysts/Institutional Investor Meet/Con. Call Updates
19 May 2026
News
Loading…
Corporate Actions dividends, bonuses, splits, buybacks, rights
No corporate actions available from NSE right now.
Board Meetings
27 Jul 2026
SENORES PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 27-Jul-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended June 2026 and Other business.
27 Jul 2026
To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters
14 May 2026
SENORES PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 14-May-2026 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2026 and Other business.
14 May 2026
To consider and approve Audited Consolidated and Standalone Financial Results Of The Company For The Quarter And financial year Ended March 31, 2026 And To Transact Other Business Matters
20 Jan 2026
SENORES PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 20-Jan-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 2025 and Other business.
20 Jan 2026
Senores Pharmaceuticals Limited has informed the exchange that the meeting of the Board of Directors of the Company is scheduled on January 20, 2026 ,inter alia, to consider and approve Un-audited Standalone and Consolidated Financial Results of the Company for the quarter and Nine Months ended December 31, 2025 and to transact other business matters
07 Jan 2026
SENORES PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 07-Jan-2026 to consider and approve Fund raising/Other business.
07 Jan 2026
Senores Pharmaceuticals Ltd has informed the exchange that the meeting of the Board of Directors of the Company is scheduled on 07/01/2026, inter alia, to consider and approveproposals for raising funds by way of issue of convertible warrants on preferential basis to the promotors/promoter group including determination of issue price.